AstraZenecaGowling WLG Acting Opposite US Giant On $7BN AstraZeneca Cancer Drug Deal
The deal will see two pharma giants collaborate to commercialise a new treatment for specific types of cancer.
April 24, 2019 at 12:09 PM
2 minute read
Latham & Watkins and Gowling WLG have taken roles on one of the biggest pharma deals of the year so far, as drug giants AstraZeneca and Daiichi Sankyo collaborate on a $6.9 billion cancer treatment.
The deal will see the global development and commercialisation of Japan-headquartered Daiichi Sankyo's lead antibody drug, trastuzumab deruxtecan. It is designed to help treat a range of cancers including breast and gastric cancer, as well as non-small cell lung and colorectal cancer.
The commercialisation agreement will involve AstraZeneca paying Daiichi $1.4 billion upfront, with subsequent payments of up to $5.55 billion once certain regulatory hurdles are crossed.
Gowling is advising AstraZeneca and has fielded a team led by London-based life sciences head Patrick Duxbury.
Latham is acting for Daiichi with an international team led by Silicon Valley partner Judith Hasko. The team includes fellow U.S.-based partners Kirt Switzer and Mandy Reeves, alongside Brussels partner Hector Armengod and Tokyo partner Nozomi Oda.
It is the latest in a series of big-ticket pharma deals in recent months. Last month, Sullivan & Cromwell, Linklaters and Simpson Thacher & Bartlett acted as German pharmaceuticals giant Merck launched a $5.9 billion hostile takeover bid for U.S. chemicals manufacturer Versum Materials.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View All
Gibson Dunn Sued by Crypto Client After Lateral Hire Causes Conflict of Interest
Australian Corporations More Concerned About Class Actions Risk, HSF Report Finds
3 minute read
Singapore Oil Tycoon Appeals 17.5 Year Prison Sentence In Fraudulent Trading Case
Charles Russell Speechlys Opens in Milan to Focus on Ultra-High Net Worth Clients
Trending Stories
- 1Judge Grants Special Counsel's Motion, Dismisses Criminal Case Against Trump Without Prejudice
- 2GEICO, Travelers to Pay NY $11.3M for Cybersecurity Breaches
- 3'Professional Misconduct': Maryland Supreme Court Disbars 86-Year-Old Attorney
- 4Capital Markets Partners Expect IPO Resurgence During Trump Administration
- 5Chief Assistant District Attorney and Litigator Shortlisted for Paulding County Judgeship
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
